Menu

Quarterly result update

Lupin Soars on USFDA Nod for Billion-Dollar Drug

Q2FY19 Results, Lupin Ltd. posted Rs 266 crores net profit

Lupin Ltd is a multinational pharmaceutical company, incorporated in the year 1968. It is the eighth-largest generic pharmaceutical company in terms of revenue globally. The company’s key business areas are...
AstraZeneca Pharma India Q1 2026: Strong Growth and Resilience

Q2FY19 Results, Aurobindo Pharma Ltd. posted Rs 611.40 crores net profit

Aurobindo Pharma Limited is a fully integrated pharmaceutical company, incorporated in the year 1986. The Company manufactures Generic pharmaceutical, Active Pharmaceuticals Ingredients (API), Formulation drugs and speciality products. The companies...